First Tracks Biotherapeutics is trading 5.05% down at $34.22, amid broader market weakness and the biotech sector’s 2.06% drop. - Shares closed up 5.60% on October 15 and 7.73% on October 14. - On October 15, the company announced a private placement of 6,106,870 shares at $32.75, for approximately $200 million. Available reporting does not establish it as the direct cause of the decline. No trading-volume data was provided.